Insilico, the largest shareholder, slightly increases stake to 39.01% via open market purchase, signaling management stability and positive shareholder value
On June 1, 2026, Insilico, the largest shareholder, acquired an additional 6,468 common shares of Daesung Microbiological Labs through open market purchase, increasing its stake from 1,475,826 to 1,482,294 shares, and raising its ownership ratio from 38.84% to 39.01%, a 0.17%p increase
The purchase price was 6,682 KRW per share, approximately 0.63% higher than the closing price of 6,640 KRW on the base date, with a total acquisition amount of about 43.2 million KRW
This small stake increase signals strengthened management stability and the largest shareholder's confidence in the company's value, potentially serving as a positive signal to minority shareholders
[AI Summary]While the open market purchase is limited in size and immediate price impact, it is evaluated as a mid-to-long-term positive factor in terms of reducing owner risk and enhancing shareholder trust
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders